In the case of NSCLC, Wang discovered that the overexpression of MIR31HG could not directly modify all epidermal growth factor receptor (EGFR), PI3K, or AKT levels but could affect the expression levels of P-EGFR, P-PIP3 and P-AKT. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.